Cost Effectiveness of Combination HIV Therapy
- 1 April 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (4), 325-330
- https://doi.org/10.2165/00019053-200017040-00002
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- An Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Regimens in HIV InfectionPharmacoEconomics, 1999
- A Prospective Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens in HIV InfectionPharmacoEconomics, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- One world, one hopeAIDS, 1998
- Modelling the Potential Economic Impact of Viral Load???Driven Triple Drug Combination Antiretroviral TherapyPharmacoEconomics, 1998
- Costs to Medicaid of Advancing Immunosuppression in an Urban HIV-Infected Patient Population in MarylandJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Lifetime Cost of Human Immunodeficiency Virus-Related Health CareJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Combination Antiretroviral Therapy in HIV InfectionPharmacoEconomics, 1996
- The Economic Costs of Caring for People with HIV Infection and AIDS in England and WalesPharmacoEconomics, 1996
- Cost Effectiveness of Antiviral Treatment with Zalcitabine plus Zidovudine for AIDS Patients with CD4+ Counts Less Than 300/??l in 5 European CountriesPharmacoEconomics, 1994